AMP18P1RA

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAMP18P1RA
Drug Alias NameIL-18bp-Fc-IL-1raIL-18bp-Fc-IL-1ra fusion protein (AmProtein)AMP18P1RA
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin 18 inhibitorsInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptorInterleukin 18
Therapy Area/IndicationsPsoriasisMyocardial IschemiaNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmProtein Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmProtein Corp
Active IndicationsN/A
Inactive IndicationsPsoriasisMyocardial IschemiaNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A